Publisher's Synopsis
Many new approaches to diagnose cancer have been identified, and many more are being developed. The two most prevalent clinical approaches for detecting cancers are biopsies followed by histology or the use of biomarkers (protein levels or nucleic acid content). An emerging central theme within this movement has been the development of nanoparticles, especially those focused on carbon dots, graphene, and gold nanoparticles in the development of biosensors for cancer detection and diagnosis. This book includes the most up-to-date point-of-care cancer detection technologies and processes, which are based on biomedical sensors, microfluidics and integrated systems engineering. It will compile detailed literature on various novel applications of nano biosensors in cancer diagnosis by primarily focusing on non-invasive biomarker detection, use of nanoparticles, and biosensor applications. It also includes current advancements and diagnostic tests that can be conducted outside of the laboratory in remote areas.
Key Features:
- Covers in detail the Role of nano biosensors for early detection of cancer
- Clinical use of nanoparticles in biosensor development is incorporated where useful
- Importance of non-invasive biomarkers for the detection of cancer is stressed
- The utility of nano biosensors in cancer diagnosis is covered particularly from a third world perspective
- Extensive references included to enhance further study
